GEORGE L FOTIADES
CIK 1202424 · Chief Executive Officer · last filed 2026-07-17
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$1.97M
Companies
5
Total Filings
209
Lifetime Open-Market Net
-$6.92M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ATR | Director | 6,446 | $132.57 | $854.5K | -$5.64M | 25 | 2026-07-17 |
| PLD | Director | 8,000 | $139.08 | $1.11M | -$796.2K | 108 | 2026-07-02 |
| CANTEL MEDICAL CORP (CMD) Delisted | Chief Executive Officer | 0 | $80.37 | $0 | -$633.6K | 19 | 2021-06-02 |
| CANTEL MEDICAL CORP (CMN) Delisted | Director | 106,151 | — | — | $142.3K | 30 | 2016-10-12 |
| Prologis, Inc. (PLD.PRSC) Delisted | Director | — | — | — | $0 | 1 | 2013-04-02 |
Recent Filings · Page 9 of 21
209 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2018-05-04 | PLD | Grant (A) | — | $0 | EDGAR |
| 2018-05-04 | ATR | Grant (A) | +1,621 | $0 | EDGAR |
| 2018-04-16 | CANTEL MEDICAL CORP (CMD) Delisted | Sell (S) | −5,400 | -$545.9K | EDGAR |
| 2018-04-03 | PLD | Grant (A) | — | $0 | EDGAR |
| 2018-01-03 | PLD | Grant (A) | — | $0 | EDGAR |
| 2017-12-19 | CANTEL MEDICAL CORP (CMD) Delisted | Sell (S) | −5,700 | -$576.2K | EDGAR |
| 2017-10-17 | CANTEL MEDICAL CORP (CMD) Delisted | Sell (S) | −6,000 | -$571.4K | EDGAR |
| 2017-10-12 | CANTEL MEDICAL CORP (CMD) Delisted | Grant (A) | +520 | $0 | EDGAR |
| 2017-10-03 | PLD | Grant (A) | — | $0 | EDGAR |
| 2017-08-01 | CANTEL MEDICAL CORP (CMD) Delisted | Mixed | −605 | $0 | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.